Shasha Wang
Qingdao University
13 Papers
Shasha Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Ferroptosis‐related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma
Ruoxi Xiao,Shasha Wang,Jing Guo,Shihai Liu,Aiping Ding,Gongjun Wang,Wenqian Li,Yuqi Zhang,Xiaoqian Bian,Shufen Zhao,Wensheng Qiu +10 more
TL;DR: The ferroptosis‐related gene signature can accurately predict the outcomes of patients with STAD, providing valuable insights for personalized treatment and may help improve the efficacy of personalized immunotherapy.
55
Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker
Shibo Wang,Xiaojuan Huang,Shufen Zhao,Jing Lv,Yi Li,Shasha Wang,Jing Guo,Yan Wang,Rui Wang,Mengqi Zhang,Wen-Sheng Qiu +10 more
TL;DR: The research illustrated the possible consequences of lipid metabolism in GC, and identified BCHE as a potential therapeutic target for GC and the LRG-based signature could independently forecast the outcome of GC patients and guide personalized therapy.
5
Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer
Xiaoxi Han,Chuanyu Leng,Shufen Zhao,Shasha Wang,Shuming Chen,Shibo Wang,Mengqi Zhang,Xiangxue Li,Yangyang Lu,Bing Wang,Wei-Wei Qi +10 more
TL;DR: Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer identifies novel prognostic markers and therapeutic targets for GC.
3
The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma
Yixin Ding,Shasha Wang,Zhenkang Qiu,Chunyang Zhu,Yan Wang,Shufen Zhao,Wensheng Qiu,Kongjia Wang,Jing Lv,Weiwei Qi +9 more
TL;DR: Combining HAIC with anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb) immunotherapy is anticipated to emerge as a novel therapeutic approach aimed at augmenting the response inside the localized tumor site and achieving prolonged survival advantages.
2
Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022)
Xiaojuan Huang,Jing Guo,Shasha Wang,Zhongkun Lin,Shufen Zhao,Wenqian Li,Yan Wang,Chunyang Zhu,Jing Lv,Wensheng Qiu +9 more
TL;DR: This study illustrates that the topic of B7-H3/CI is very popular and has great clinical implications and that the number of correlative publications will continue to increase and that it may lead to new research trends.
2